| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.36▲ | 1.37▲ | 1.37▲ | 1.32▲ | 1.43▼ |
| MA10 | 1.38▼ | 1.39▼ | 1.39▼ | 1.29▲ | 1.16▲ |
| MA20 | 1.40▼ | 1.39▼ | 1.38▼ | 1.43▼ | 0.96▲ |
| MA50 | 1.38▼ | 1.31▲ | 1.31▲ | 1.08▲ | 1.21▲ |
| MA100 | 1.31▲ | 1.32▲ | 1.40▼ | 0.94▲ | 1.72▼ |
| MA200 | 1.33▲ | 1.53▼ | 1.28▲ | 1.09▲ | 1.63▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | -0.010▼ | -0.007▼ | -0.024▼ | 0.098▲ |
| RSI | 47.412▼ | 52.129▲ | 54.038▲ | 54.250▲ | 57.334▲ |
| STOCH | 5.952▼ | 9.524▼ | 16.653▼ | 53.277 | 43.782 |
| WILL %R | -64.286 | -77.273▼ | -77.273▼ | -31.429 | -59.299 |
| CCI | -49.268 | -98.420 | -77.778 | 51.898 | 62.122 |
|
Tuesday, September 29, 2026 01:30 AM
Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative medicine company, today announced that Naveen Jain, founder and Chief Executive Officer of Viome Life Sciences Inc.
|
|
Thursday, September 24, 2026 06:16 AM
Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced an initial closing generating over $10 million in gross cash proceeds from ...
|
|
Tuesday, September 15, 2026 06:42 AM
Celularity ( ) has provided an update. On September 11, 2026, Celularity Inc. said it had regained compliance with Nasdaq’s minimum bid price requirement and the minimum market ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/09/26 | 1.38 | 1.3999 | 1.3343 | 1.37 | 39,646 |
| 28/09/26 | 1.40 | 1.46 | 1.35 | 1.40 | 113,620 |
| 25/09/26 | 1.33 | 1.41 | 1.32 | 1.38 | 166,069 |
| 24/09/26 | 1.17 | 1.35 | 1.17 | 1.32 | 454,723 |
| 23/09/26 | 1.17 | 1.18 | 1.13 | 1.15 | 77,117 |
| 22/09/26 | 1.22 | 1.26 | 1.16 | 1.18 | 154,730 |
| 21/09/26 | 1.27 | 1.33 | 1.24 | 1.24 | 214,037 |
| 18/09/26 | 1.28 | 1.35 | 1.22 | 1.31 | 188,400 |
| 17/09/26 | 1.29 | 1.38 | 1.27 | 1.27 | 77,758 |
| 16/09/26 | 1.26 | 1.3891 | 1.21 | 1.29 | 181,095 |
|
|
||||
|
|
||||
|
|